4.7 Article

Type I Interferon Production Induced by Streptococcus pyogenes-Derived Nucleic Acids Is Required for Host Protection

期刊

PLOS PATHOGENS
卷 7, 期 5, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.ppat.1001345

关键词

-

资金

  1. Austrian Science Fund (FWF) [SFB F28, I287-B09, I289-B09]
  2. L'Oreal-UNESCO
  3. Austrian Science Fund (FWF) [I 289] Funding Source: researchfish
  4. Austrian Science Fund (FWF) [I289] Funding Source: Austrian Science Fund (FWF)

向作者/读者索取更多资源

Streptococcus pyogenes is a Gram-positive human pathogen that is recognized by yet unknown pattern recognition receptors (PRRs). Engagement of these receptor molecules during infection with S. pyogenes, a largely extracellular bacterium with limited capacity for intracellular survival, causes innate immune cells to produce inflammatory mediators such as TNF, but also type I interferon (IFN). Here we show that signaling elicited by type I IFNs is required for successful defense of mice against lethal subcutaneous cellulitis caused by S. pyogenes. Type I IFN signaling was accompanied with reduced neutrophil recruitment to the site of infection. Mechanistic analysis revealed that macrophages and conventional dendritic cells (cDCs) employ different signaling pathways leading to IFN-beta production. Macrophages required IRF3, STING, TBK1 and partially MyD88, whereas in cDCs the IFN-beta production was fully dependent on IRF5 and MyD88. Furthermore, IFN-beta production by macrophages was dependent on the endosomal delivery of streptococcal DNA, while in cDCs streptococcal RNA was identified as the IFN-beta inducer. Despite a role of MyD88 in both cell types, the known IFN-inducing TLRs were individually not required for generation of the IFN-beta response. These results demonstrate that the innate immune system employs several strategies to efficiently recognize S. pyogenes, a pathogenic bacterium that succeeded in avoiding recognition by the standard arsenal of TLRs.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Allergy

IgE antibodies increase honeybee venom responsiveness and detoxification efficiency of mast cells

Philipp Starkl, Nicolas Gaudenzio, Thomas Marichal, Laurent L. Reber, Riccardo Sibilano, Martin L. Watzenboeck, Frederic Fontaine, Andre C. Mueller, Mindy Tsai, Sylvia Knapp, Stephen J. Galli

Summary: The study found that IgE sensitization enhances MC detoxification of honeybee venom by promoting proteolytic degradation and heparin-related interference with toxicity. This research emphasizes the importance of IgE, MCs, and specific MC products in defense against honeybee venom.

ALLERGY (2022)

Article Respiratory System

Multi-omics profiling predicts allograft function after lung transplantation

Martin L. Watzenboeck, Anna-Dorothea Gorki, Federica Quattrone, Riem Gawish, Stefan Schwarz, Christopher Lambers, Peter Jaksch, Karin Lakovits, Sophie Zahalka, Nina Rahimi, Philipp Starkl, Doerte Symmank, Tyler Artner, Celine Pattaroni, Nikolaus Fortelny, Kristaps Klavins, Florian Frommlet, Benjamin J. Marsland, Konrad Hoetzenecker, Stefanie Widder, Sylvia Knapp

Summary: Lung transplantation is the ultimate treatment option for patients with end-stage respiratory diseases, but the mortality rate is high due to chronic lung allograft dysfunction (CLAD). The mechanisms leading to CLAD are not well understood due to insufficient understanding of post-transplant adaptation processes. This study analyzed bronchoalveolar lavage samples from lung recipients and donors, and found that recipient-specific and environmental factors shape the long-term lung microbiome. Certain bacterial strains were found to be correlated with underlying lung diseases even after transplantation. Machine learning techniques accurately predicted future changes in lung function, with the microbial profiles showing high predictive power. The study highlights the importance of understanding lung adaptation processes and the role of microbiome in predicting allograft function.

EUROPEAN RESPIRATORY JOURNAL (2022)

Article Biochemistry & Molecular Biology

Murine Ex Vivo Cultured Alveolar Macrophages Provide a Novel Tool to Study Tissue-Resident Macrophage Behavior and Function

Anna-Dorothea Gorki, Dorte Symmank, Sophie Zahalka, Karin Lakovits, Anastasiya Hladik, Brigitte Langer, Barbara Maurer, Veronika Sexl, Renate Kain, Sylvia Knapp

Summary: This study proposes a novel culture model for studying and expanding murine primary alveolar macrophages (AMs) in vitro over several months. The cultured AMs maintain typical features and surface markers, and exhibit similar functions and transcriptional profile to primary AMs. When transferred into AM-deficient mice, the cultured AMs efficiently engraft in the lung and perform key macrophage functions.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2022)

Article Biology

ACE2 is the critical in vivo receptor for SARS-CoV-2 in a novel COVID-19 mouse model with TNF- and IFNγ-driven immunopathology

Riem Gawish, Philipp Starkl, Lisabeth Pimenov, Anastasiya Hladik, Karin Lakovits, Felicitas Oberndorfer, Shane J. F. Cronin, Anna Ohradanova-Repic, Gerald Wirnsberger, Benedikt Agerer, Lukas Endler, Tumay Capraz, Jan W. Perthold, Domagoj Cikes, Rubina Koglgruber, Astrid Hagelkruys, Nuria Montserrat, Ali Mirazimi, Louis Boon, Hannes Stockinger, Andreas Bergthaler, Chris Oostenbrink, Josef M. Penninger, Sylvia Knapp

Summary: Despite progress in understanding COVID-19, limited mechanistic insight into immunological factors and disease severity remains. Scientists generated a mouse-adapted SARS-CoV-2 strain, maVie16, and found that cytokine-driven immunopathology and ACE2 dependence determine disease severity. This study provides a new tool for discovering therapies.
Article Microbiology

Metagenomic sequencing reveals time, host, and body compartment-specific viral dynamics after lung transplantation

Stefanie Widder, Irene Goerzer, Benjamin Friedel, Nina Rahimi, Stefan Schwarz, Peter Jaksch, Sylvia Knapp, Elisabeth Puchhammer-Stoeckl

Summary: This study provides a detailed analysis of virome dynamics after lung transplantation, revealing host, body compartment, and time-specific dependency patterns among viruses. The results also suggest genetic adaptation to the host microenvironment at the level of the virome and support the hypothesis of functional complementarity between Anellovirus groups and other persistent viruses.

MICROBIOME (2022)

Article Multidisciplinary Sciences

Nonredundancy of IL-1α and IL-1β is defined by distinct regulation of tissues orchestrating resistance versus tolerance to infection

Kevin Eislmayr, Annika Bestehorn, Luisa Morelli, Martina Borroni, Lieselotte Vande Walle, Mohamed Lamkanfi, Pavel Kovarik

Summary: IL-1α and IL-1β have distinct functions during infection, with IL-1α governing metabolic pathway reprogramming in the liver for infection tolerance, while IL-1β is essential for pathogen clearance and regulation of the spleen transcriptome.

SCIENCE ADVANCES (2022)

Article Medicine, Research & Experimental

Clinical grade ACE2 as a universal agent to block SARS-CoV-2 variants

Vanessa Monteil, Brett Eaton, Elena Postnikova, Michael Murphy, Benedict Braunsfeld, Ian Crozier, Franz Kricek, Janine Niederhofer, Alice Schwarzbock, Helene Breid, Stephanie Devignot, Jonas Klingstrom, Charlotte Thalin, Max J. Kellner, Wanda Christ, Sebastian Havervall, Stefan Mereiter, Sylvia Knapp, Anna Sanchez Jimenez, Agnes Bugajska-Schretter, Alexander Dohnal, Christine Ruf, Romana Gugenberger, Astrid Hagelkruys, Nuria Montserrat, Ivona Kozieradzki, Omar Hasan Ali, Johannes Stadlmann, Michael R. Holbrook, Connie Schmaljohn, Chris Oostenbrink, Robert H. Shoemaker, Ali Mirazimi, Gerald Wirnsberger, Josef M. Penninger

Summary: The emergence of multiple SARS-CoV-2 variants has raised concerns due to reduced vaccine efficacy and resistance to neutralizing antibody therapies. However, research shows that soluble ACE2 can inhibit current SARS-CoV-2 variants, providing proof of principle for a pan-SARS-CoV-2 therapeutic.

EMBO MOLECULAR MEDICINE (2022)

Article Gastroenterology & Hepatology

Soluble TREM2 levels reflect the recruitment and expansion of TREM2+macrophages that localize to fibrotic areas and limit NASH

Tim Hendrikx, Florentina Porsch, Mate G. Kiss, Dragana Rajcic, Nikolina Papac-Milicevic, Constanze Hoebinger, Laura Goederle, Anastasiya Hladik, Lisa E. Shaw, Hauke Horstmann, Sylvia Knapp, Sophia Derdak, Martin Bilban, Lena Heintz, Marcin Krawczyk, Rafael Paternostro, Michael Trauner, Matthias Farlik, Dennis Wolf, Christoph J. Binder

Summary: This study investigates the role of bone marrow-derived TREM2-expressing macrophages in non-alcoholic steatohepatitis (NASH). The results show that these macrophages are involved in hepatocellular damage, inflammation, and fibrosis in the liver. Soluble TREM2 levels in the blood are identified as a potential circulating marker for NASH.

JOURNAL OF HEPATOLOGY (2022)

Article Immunology

Trained immunity of alveolar macrophages requires metabolic rewiring and type 1 interferon signaling

Sophie Zahalka, Philipp Starkl, Martin L. Watzenboeck, Asma Farhat, Mariem Radhouani, Florian Deckert, Anastasiya Hladik, Karin Lakovits, Felicitas Oberndorfer, Caroline Lassnig, Birgit Strobl, Kristaps Klavins, Mai Matsushita, David E. Sanin, Katarzyna M. Grzes, Edward J. Pearce, Anna-Dorothea Gorki, Sylvia Knapp

Summary: Environmental microbial exposure has a profound impact on pulmonary immune memory, particularly on alveolar macrophages (AMs). AMs showed enhanced reactivity to pneumococcal challenge after intranasal exposure to ambient lipopolysaccharide (LPS). The training effect of AMs was found to be dependent on type 1 interferon signaling and inhibited by fatty acid oxidation and glutaminolysis. Moreover, adoptive transfer of trained AMs resulted in increased bacterial loads and tissue damage upon pneumococcal infection.

MUCOSAL IMMUNOLOGY (2022)

Editorial Material Biotechnology & Applied Microbiology

CRISPR comes a-knock-in to reprogram antibodies in vivo

Harald Hartweger, Michel C. Nussenzweig

Summary: Reprogramming of antibody responses in mice is achieved by delivering SaCas9, single guide RNA (sgRNA), and a repair template using adeno-associated virus.

NATURE BIOTECHNOLOGY (2022)

Article Biology

A neutrophil-B-cell axis impacts tissue damage control in a mouse model of intraabdominal bacterial infection via Cxcr4

Riem Gawish, Barbara Maier, Georg Obermayer, Martin L. Watzenboeck, Anna-Dorothea Gorki, Federica Quattrone, Asma Farhat, Karin Lakovits, Anastasiya Hladik, Ana Korosec, Arman Alimohammadi, Ildiko Mesteri, Felicitas Oberndorfer, Fiona Oakley, John Brain, Louis Boon, Irene Lang, Christoph J. Binder, Sylvia Knapp

Summary: Sepsis can lead to multiorgan failure and therapeutic options are limited. This study establishes a mouse model of long-lasting disease tolerance during severe sepsis and highlights the role of neutrophils and B cells in tissue integrity.
Article Immunology

B cell-intrinsic requirement for WNK1 kinase in antibody responses in mice

Darryl A. Hayward, Lesley Vanes, Stefanie Wissmann, Sujana Sivapatham, Harald Hartweger, Joshua Biggs O'May, Leonard L. de Boer, Richard Mitter, Robert Kochl, Jens Stein, Victor L. J. Tybulewicz

Summary: In this study, the critical role of WNK1 kinase in regulating migration, adhesion, and activation of B cells was demonstrated. WNK1 transduces signals from BCR, CXCR5, and CD40, and controls the migration of naive and activated B cells as well as their interactions with T cells. Furthermore, WNK1 is necessary for BCR- and CD40-induced proliferation and efficient B cell-T cell collaboration in vivo.

JOURNAL OF EXPERIMENTAL MEDICINE (2023)

Review Oncology

Combined Vaccination with B Cell Peptides Targeting Her-2/neu and Immune Checkpoints as Emerging Treatment Option in Cancer

Joshua Tobias, Mirjana Drinic, Anna Schmid, Anastasiya Hladik, Martin L. Watzenboeck, Claire Battin, Erika Garner-Spitzer, Peter Steinberger, Michael Kundi, Sylvia Knapp, Christoph C. Zielinski, Ursula Wiedermann

Summary: Therapies with monoclonal antibodies (mAbs) have revolutionized cancer treatment, but they have limitations such as frequent administration, limited clinical response duration, and immune-related adverse events. Vaccines using mimotopes that induce immunological memory and produce antibodies similar to mAbs have been proposed as an alternative. This review focuses on active immunization against two cancer-relevant targets and discusses safety concerns and future prospects.

CANCERS (2022)

Article Biology

HUWE1 controls tristetraprolin proteasomal degradation by regulating its phosphorylation

Sara Scinicariello, Adrian Soderholm, Markus Schaefer, Alexandra Shulkina, Irene Schwartz, Kathrin Hacker, Rebeca Gogova, Robert Kalis, Kimon Froussios, Valentina Budroni, Annika Bestehorn, Tim Clausen, Pavel Kovarik, Johannes Zuber, Gijs A. Versteeg

Summary: Tristetraprolin (TTP) stability is controlled by factors including lysine-ubiquitination and phosphorylation. The E3 ligase HUWE1 was identified as a regulator of TTP stability, indirectly controlling its phosphorylation. This study provides new insights into the regulation of TTP and its impact on immune response.
Article Immunology

CD4 binding site immunogens elicit heterologous anti-HIV-1 neutralizing antibodies in transgenic and wild-type animals

Harry B. Gristick, Harald Hartweger, Maximilian Loewe, Jelle van Schooten, Victor Ramos, Thiago Y. Oliveira, Yoshiaki Nishimura, Nicholas S. Koranda, Abigail Wall, Kai -Hui Yao, Daniel Poston, Anna Gazumyan, Marie Wiatr, Marcel Horning, Jennifer R. Keeffe, Magnus A. G. Hoffmann, Zhi Yang, Morgan E. Abernathy, Kim-Marie A. Dam, Han Gao, Priyanthi N. P. Gnanapragasam, Leesa M. Kakutani, Ana Jimena Pavlovitch-Bedzyk, Michael S. Seaman, Mark Howarth, Andrew T. Mcguire, Leonidas Stamatatos, Malcolm A. Martin, Anthony P. West Jr, Michel C. Nussenzweig, Pamela J. Bjorkman

Summary: Passive transfer of broadly neutralizing anti-HIV-1 antibodies is a strategy to protect against infection, but eliciting these antibodies through vaccination has been challenging. Researchers have successfully induced CD4 binding site (CD4bs) antibody responses using the antibody IOMA, which has potential as a vaccine strategy to generate broadly neutralizing antibodies against HIV-1.

SCIENCE IMMUNOLOGY (2023)

暂无数据